Catalyst Wire Dossier Catalyst Wire Dossier

Oxymetazoline ophthalmic solution

Oxymetazoline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oxymetazoline ophthalmic solution, covering 2026-03-09 to 2026-03-09. Get the full timeline:

Most recent: Clinical Trial Update: Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis [Phase 3]

See pricing